Literature DB >> 974553

Raynaud's disease and oral contraceptives.

P E Jarrett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974553      PMCID: PMC1688302          DOI: 10.1136/bmj.2.6037.699

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.

Authors:  P BRAKMAN; T ASTRUP
Journal:  Lancet       Date:  1964-07-04       Impact factor: 79.321

2.  BLOOD VISCOSITY AND RAYNAUD'S DISEASE.

Authors:  R PRINGLE; D N WALDER; J P WEAVER
Journal:  Lancet       Date:  1965-05-22       Impact factor: 79.321

3.  Progesterone oral contraception and blood coagulation.

Authors:  L Poller; J M Thomson; A Tabiowo; C M Priest
Journal:  Br Med J       Date:  1969-03-01
  3 in total
  1 in total

Review 1.  Hormonal steroid contraceptives: a further review of adverse reactions.

Authors:  E G McQueen
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.